Global Insulin Delivery Pen Market Analysis 2012-2017 - Forecasts 2018-2025 Featuring Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed & Biocon

DUBLIN, Dec. 5, 2017 /PRNewswire/ --

The "Global Insulin Delivery Pen Market Analysis, Size, Share, Segmentation and Competitive Landscape (2012 - 2017) and Future Forecast (2018 - 2025)" report has been added to Research and Markets' offering.

The report Global Insulin Delivery Pen Market Analysis, Size, Share, Segmentation and Competitive Landscape (2012 - 2017) and Future Forecast (2018 - 2025) offers the most up-to-date industry data on the actual market situation and future outlook for insulin pen across the ten major markets (10MM).

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025. A comprehensive analysis has been done on market share of insulin pen segment.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

• Novo Nordisk
• Eli Lilly
• Sanofi
• Owen Mumford
• Ypsomed
• Biocon Ltd.

Key Findings:

• Germany accounted for 15% of the insulin delivery pen market in 2017
• China dominates the reusable insulin delivery pen market
• Reusable insulin delivery pen has the highest volume share in the overall insulin delivery pen market
• Disposable insulin delivery pen is expected to register a faster value growth during 2018-2025
• Japan is the third largest insulin delivery pen market
• Flexpen, Solostar and KwikPen are the leading brand in the insulin delivery pen sector

The Latest Industry Data Included in this Report:

• Diabetes Population in 10 major market(10MM) 2011-2025
• Insulin Users Insights in 10 major market(10MM) 2011-2025
• Overall Insulin Delivery Pen Users, 2011-2025
• Overall Insulin Delivery Pen Market Size, 2011-2025
• Insulin Delivery Pen Market Size by Product Segments, 2011-2025
• Growth Rates of the Overall Market and Different Product Segments, 2011-2025
• Shares of Different Product Segments of the Overall Market, 2011- 2025
• Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current Product Portfolios and Recent Development

The Report Facilitates Answer the Subsequent Questions:

• What is the size of the insulin delivery pen market in 10 major market(10MM)?
• How much reusable and disposable pen users in 10 major market(10MM)?
• How is the insulin delivery pen market divided into two different types of segments?
• How are the overall market and segments types growing?
• How is the market predicted to develop in the future?
• Who are the market players?

Key Topics Covered:

1. Executive Summary

2. Insulin Delivery Pen Market in Top Ten Countries - Market Overview
2.1 10 Countries - Overall Insulin Pen Users & Forecast
2.2 10 Countries - Overall Insulin Pen Market & Forecast
2.3 10 Countries - Overall Insulin Pen Users Share & Forecast
2.4 10 Countries - Overall Insulin Pen Market Share & Forecast

3. Insulin Delivery Pen Market Drivers and Barriers
3.1 Market Drivers
3.2 Market Barriers

4. Insulin Delivery Pen Market in Top Ten Countries - Geographical Landscape
4.1 United States
4.2 Germany
4.3 France
4.4 Italy
4.5 Spain
4.6 United Kingdom
4.7 Japan
4.8 China
4.9 India
4.10 Brazil

5. Key Companies Analysis

• Biocon Ltd.
• Eli Lilly
• Novo Nordisk
• Owen Mumford
• Sanofi
• Ypsomed

For more information about this report visit https://www.researchandmarkets.com/research/2zs6mn/global_insulin

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com